Merck & Co., Inc. Other Preferred Stock Dividends and Adjustments
Merck & Co., Inc. (MRK) reported Other Preferred Stock Dividends and Adjustments of $3.00 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherPreferredStockDividendsAndAdjustments · last filed 2011-05-09
- Merck & Co., Inc. other preferred stock dividends and adjustments for the quarter ending 2011-03-31 was $3.00M, a 200.00% increase year-over-year.
- Merck & Co., Inc. other preferred stock dividends and adjustments for the quarter ending 2010-12-31 was -$3.30M, a 112.79% decline year-over-year.
- Merck & Co., Inc. other preferred stock dividends and adjustments for the quarter ending 2010-09-30 was $1.20M, a 89.74% decline year-over-year.
- Merck & Co., Inc. other preferred stock dividends and adjustments for the quarter ending 2010-06-30 was $2.90M, a 39.58% decline year-over-year.
- Merck & Co., Inc. other preferred stock dividends and adjustments for fiscal 2010 was $2.00M, a 95.65% decline from fiscal 2009.
- Merck & Co., Inc. other preferred stock dividends and adjustments for fiscal 2009 was $46.00M, a 130.00% increase from fiscal 2008.
- Merck & Co., Inc. other preferred stock dividends and adjustments for fiscal 2008 was $20.00M.
| Period end | Other Preferred Stock Dividends and Adjustments 3 month | Other Preferred Stock Dividends and Adjustments 6 month | Other Preferred Stock Dividends and Adjustments 9 month | Other Preferred Stock Dividends and Adjustments 12 month |
|---|---|---|---|---|
| 2011-03-31 | $3.00M 10-Q · filed 2011-05-09 | -$300.00K derived: sum of 2 quarters · filed 2011-05-09 | $900.00K derived: sum of 3 quarters · filed 2011-05-09 | $3.80M derived: sum of 4 quarters · filed 2011-05-09 |
| 2010-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$2.10M derived: sum of 2 quarters · filed 2011-02-28 | $800.00K derived: sum of 3 quarters · filed 2011-02-28 | $2.00M 10-K · filed 2011-02-28 |
| 2010-09-30 | $1.20M 10-Q · filed 2010-11-08 | $4.10M derived: sum of 2 quarters · filed 2010-11-08 | $5.30M 10-Q · filed 2010-11-08 | $30.90M derived: sum of 4 quarters · filed 2011-05-09 |
| 2010-06-30 | $2.90M 10-Q · filed 2010-08-06 | $4.20M 10-Q · filed 2010-08-06 | $29.70M derived: sum of 3 quarters · filed 2011-05-09 | $41.40M derived: sum of 4 quarters · filed 2011-05-09 |
| 2010-03-31 | $1.00M 10-Q · filed 2011-05-09 | $26.80M derived: sum of 2 quarters · filed 2011-05-09 | $38.50M derived: sum of 3 quarters · filed 2011-05-09 | $43.30M derived: sum of 4 quarters · filed 2011-05-09 |
| 2009-12-31 | $25.80M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $37.50M derived: sum of 2 quarters · filed 2011-02-28 | $42.30M derived: sum of 3 quarters · filed 2011-02-28 | $46.00M 10-K · filed 2011-02-28 |
| 2009-09-30 | $11.70M 10-Q · filed 2010-11-08 | $16.50M derived: sum of 2 quarters · filed 2010-11-08 | $20.20M 10-Q · filed 2010-11-08 | |
| 2009-06-30 | $4.80M 10-Q · filed 2010-08-06 | $9.00M 10-Q · filed 2010-08-06 | ||
| 2008-12-31 | $20.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |